The man who first taught me what Parkinson's looks like up close was not the patient. He was the patient's husband, and he had stopped being able to smell his coffee six years before his wife's neurologist said the word out loud. He didn't know to tell anyone. Anosmia, the loss of smell, is one of the quietest warning signs the body gives, and it almost never travels alone. By the time his wife's right hand began to tremor at rest, by the time her arm stopped swinging when she walked, the disease had been moving through her nervous system for a decade.
I have sat with a lot of families since then. What I have learned is that the story of Parkinson's almost always starts long before the diagnosis, and that the diagnosis itself is only the beginning of a different kind of attention.
This is a long subject. I will not rush it.
What Parkinson's Actually Is
Parkinson's disease is a progressive neurodegenerative disorder. In the simplest terms, the brain begins losing the cells that produce dopamine, a neurotransmitter that helps coordinate smooth, controlled movement. Most of those cells live in a region called the substantia nigra, deep in the midbrain. As they die off, the brain loses some of the signaling it relies on to move the body the way the mind intends.
Around one million Americans are living with Parkinson's today, and roughly 90,000 receive a new diagnosis each year, according to the Parkinson's Foundation. The disease shows up most often after age 60, though about four percent of those diagnosed are under 50, what doctors call early-onset Parkinson's. Men are diagnosed roughly one and a half times more often than women, for reasons researchers are still working out.
The underlying biology involves more than dopamine. A protein called alpha-synuclein begins to misfold and clump inside neurons, forming the deposits known as Lewy bodies. There is growing evidence (the Braak hypothesis) that some of this damage may begin in the gut and travel up the vagus nerve to the brain, which is one reason chronic constipation can precede motor symptoms by years.
There is still no biomarker blood test for Parkinson's. Diagnosis remains clinical, meaning a neurologist makes the call based on history, examination, and how the body responds to dopamine-replacement medication. A newer test, the alpha-synuclein seed amplification assay reported in Lancet Neurology in 2023, is beginning to change that picture in research settings, but it is not yet routine in a community clinic.
The Symptoms Before the Symptoms
When most people think of Parkinson's, they think of the tremor. The tremor is real, and it is one of the four cardinal motor signs that movement disorder specialists use, sometimes remembered as TRAP:
- Tremor at rest, usually starting on one side
- Rigidity, often described as cogwheel stiffness in the limbs
- Akinesia or bradykinesia, the slowness and shrinking of movement
- Postural instability, balance loss that tends to come later
But by the time those signs are obvious enough to bring someone to a neurologist, the disease has often been at work for years. The non-motor symptoms are the early signal, and they are the ones families miss most often because they look like aging or like a dozen other things.
Loss of smell is one of them. Studies estimate that 70 to 90 percent of people with Parkinson's have a measurable reduction in their sense of smell, frequently years before diagnosis. REM sleep behavior disorder, in which the body fails to paralyze itself during REM sleep and people act out vivid dreams, sometimes violently, is another. Multiple long-term cohorts suggest that 80 to 90 percent of people with isolated REM sleep behavior disorder will convert to Parkinson's or a related condition within 10 to 15 years. It is the strongest known prodromal marker we have.
The other quiet signs are easier to overlook. Stubborn constipation that does not respond to fiber or hydration. Depression and anxiety that arrive without an obvious life cause; studies suggest up to half of people with Parkinson's experience mood symptoms, and these often appear before motor symptoms. Mild cognitive changes such as slowed thinking, trouble finding words, and executive function struggles. Lightheadedness on standing (orthostatic hypotension). Bladder urgency. A handwriting that has gotten smaller and tighter over the past two years.
None of these signs alone mean Parkinson's. Taken together, in a particular person, they sometimes do.
Getting the Right Diagnosis
When something seems wrong, the first conversation matters. A primary care physician can recognize the pattern, but the person you want at the table is a neurologist who specializes in movement disorders. The difference is not a matter of credentials. It is a matter of how many times that doctor has watched somebody walk down a hallway and known, within ten seconds, what they were looking at.
A good diagnostic workup typically includes a careful history (sleep, smell, constipation, mood, handwriting, family history), a full neurological exam, and an MRI to rule out other conditions like strokes, tumors, and normal pressure hydrocephalus. In ambiguous cases the neurologist may order a DaTscan, a SPECT imaging study that shows the density of dopamine transporters in the brain. A DaTscan cannot diagnose Parkinson's by itself, but it can help distinguish Parkinson's from essential tremor or drug-induced parkinsonism, conditions that look similar but respond to entirely different treatments.
The most useful diagnostic test is also the simplest one. If a person's symptoms improve meaningfully on carbidopa-levodopa, that response confirms the diagnosis in the great majority of cases.
Several conditions can imitate Parkinson's, particularly in the early stages: essential tremor (which usually involves both hands and worsens with action, not at rest), progressive supranuclear palsy, multiple system atrophy, and vascular parkinsonism caused by small strokes. The singer Linda Ronstadt was told for years that she had Parkinson's. In 2019 her diagnosis was revised to progressive supranuclear palsy, a related but more aggressive disorder. These distinctions matter because the treatments and trajectories diverge.
Treatment That Actually Helps
There is no cure for Parkinson's disease. There are, however, treatments that genuinely work, and there are decisions about timing and combination that benefit from a doctor who knows the territory.
Carbidopa-levodopa remains the gold standard, half a century after it was introduced. Levodopa crosses the blood-brain barrier and is converted to dopamine inside the brain; carbidopa keeps that conversion from happening too soon in the bloodstream. For most people, it is the single most effective drug we have for the motor symptoms of Parkinson's. The complications come over the long term: dyskinesia (involuntary writhing movements) and motor fluctuations as the medication's effect rises and falls between doses. One practical detail patients learn the hard way: protein in the gut competes with levodopa for absorption, so most clinicians suggest taking the dose 30 minutes before a protein-heavy meal. Iron supplements can also bind levodopa and reduce its effectiveness if taken at the same time.
Dopamine agonists like pramipexole and ropinirole mimic dopamine's effect directly. They are often used in younger patients to delay starting levodopa, though they carry a notable risk. A minority of patients develop impulse control disorders, such as compulsive gambling, shopping, eating, or sexual behavior, that can devastate families before the connection to the medication is made. Every patient on these drugs should know to watch for the pattern.
MAO-B inhibitors (rasagiline, selegiline, safinamide) offer modest symptomatic benefit and are debated as possibly slowing disease progression. COMT inhibitors like entacapone extend the working time of each levodopa dose. Amantadine can help reduce dyskinesias. Anticholinergics still have a role for tremor in some cases but are used cautiously in older adults because of their effects on memory and confusion.
When medication alone stops keeping up, typically after several years and when on-off fluctuations become disabling, deep brain stimulation (DBS) becomes a serious option. Electrodes are implanted into specific brain targets (the subthalamic nucleus or globus pallidus interna), and a pacemaker-like device delivers steady electrical signals that smooth motor symptoms and often allow patients to lower their medication doses. DBS is not a cure and does not slow the disease, but for the right candidate it can return years of better function. For tremor-dominant patients who are not surgical candidates, MRI-guided focused ultrasound thalamotomy, FDA-approved in 2018, offers a non-invasive alternative.
For advanced motor fluctuations, the carbidopa-levodopa intestinal gel (Duopa) delivers medication continuously through a small pump and tube. Inhaled levodopa (Inbrija) was approved as a fast-acting rescue for sudden off-periods.
Ahead of these, in clinical trials, are alpha-synuclein-targeted antibody therapies (prasinezumab and cinpanemab among them) designed to slow disease progression rather than just treat symptoms. Early results have been disappointing. The work continues, and so does honest caution about overselling what is not yet proven. GLP-1 agonists, the same drug class that produced Ozempic, have shown intriguing but inconsistent signals in Parkinson's trials going back to the 2017 Lancet exenatide study.
There is reason for hope. There is also reason to be skeptical of any newsletter or product claiming that hope has arrived.
What Exercise Does
Of everything I could tell you in this article, the single most evidence-supported thing a person with Parkinson's can do for themselves is move their body, hard and often.
The SPARX trial, published in JAMA Neurology in 2018, randomized newly diagnosed Parkinson's patients to either high-intensity treadmill exercise, moderate-intensity exercise, or usual care. The high-intensity group showed slower progression of motor symptoms over six months than the usual care group. It is one of the clearest signals in the field that exercise is not just supportive. It appears to modify the course of the disease itself.
Real programs have grown out of this evidence. Rock Steady Boxing, started by a former prosecutor diagnosed in his forties, uses non-contact boxing training for balance, power, and coordination. There are hundreds of affiliated programs across the country. LSVT BIG (for movement) and LSVT LOUD (for speech) are intensive structured therapies, usually 16 sessions over four weeks, that train the brain to push past the small, soft default that Parkinson's imposes. PWR! Moves, short for Parkinson Wellness Recovery, teaches large-amplitude, multidirectional movements as a daily practice.
None of this replaces medication. All of it changes outcomes. Tai chi has good evidence for balance and falls reduction. Aquatic therapy works well for those whose balance no longer tolerates land-based exercise. Walking, the simplest of all, still counts when done with intention and challenge. Pairing movement work with a strong falls-prevention program is one of the most concrete decisions a family can make in the first year after diagnosis.
Diet plays a quieter supporting role. The Mediterranean and MIND diet patterns have shown associations with slower cognitive decline. Adequate fiber and hydration help the constipation that frequently shadows the disease. Beyond that, supplement promises should be treated with the skepticism appropriate to a market eager to sell to vulnerable people. The honest piece I would point a family to is the one on evidence-based supplements.
What Caregivers Carry
My years of sitting with families have taught me that the diagnosis sits differently on the patient and on the partner. The patient learns to live with a body that no longer cooperates. The partner learns to live with a person who is and is not the person they married. Both of these are griefs. Neither of them is selfish.
Quality-of-life research consistently ranks Parkinson's caregiving burden among the highest of any chronic illness. The combination of motor fluctuations, sleep disruption, cognitive change, and the long, uneven trajectory makes it different from a disease with a clear beginning and end. The transition from spouse to caregiver is a quiet kind of grief that does not have its own greeting card.
I think of a man I met in a support group years ago. His wife had advanced Parkinson's, and he had kept mowing his lawn at 7 a.m. every Saturday for forty years. When I asked him about it once, he said, "If I stop mowing, it means things are different." He kept mowing until the week she moved into full-time care. That instinct, to hold the shape of an ordinary life as long as possible, is one of the most human things I have ever watched a person do.
The practical work is real. Freezing of gait, in which the feet seem to glue to the floor mid-step, is a leading cause of falls; learning the cueing tricks (counting, marching, stepping over an imagined line) belongs in every family's toolkit. Aspiration risk grows as swallowing weakens; a speech-language pathologist's assessment is worth scheduling before anyone thinks it is needed. Home modifications like grab bars, raised toilet seats, removing throw rugs, and lighting the path to the bathroom overlap heavily with the broader work of aging in place and should not wait for the first fall.
There is a later conversation, too, that families benefit from having earlier than they want to. The trajectory of Parkinson's makes hospice timing genuinely difficult. The disease does not always have the clean late-stage decline that hospice criteria were written around. But Medicare's hospice benefit does cover advanced Parkinson's, and the support it provides (nursing, aide hours, chaplaincy, equipment, grief counseling for the family) can be transformative when invoked at the right time. The companion piece on palliative and hospice care walks through how the benefit actually works.
If you are the caregiver reading this, I will say what I say to every family I sit with: you cannot pour from an empty cup, and you cannot be replaced by anyone else in this role, and both of those things are true at once. You will need help. Ask for it before you think you do.
Resources Worth Knowing About
A few organizations have earned the trust of the Parkinson's community over decades, and they are worth bookmarking on the day of diagnosis.
- Parkinson's Foundation (parkinson.org). Patient education, a state-by-state Centers of Excellence directory, and a 24/7 helpline at 1-800-4PD-INFO staffed by trained information specialists.
- Michael J. Fox Foundation (michaeljfox.org). Research-focused, with a strong clinical trial matching tool for patients who want to participate in studies.
- American Parkinson Disease Association (apdaparkinson.org). Chapter network across the country, support groups, and excellent printable guides.
- Davis Phinney Foundation. Quality-of-life programming, including the Victory Summit events and the Every Victory Counts manual — one of the most useful single resources a newly diagnosed family can hold in their hands.
- Rock Steady Boxing (rocksteadyboxing.org). Locator for the nearest affiliated training program.
Michael J. Fox himself was diagnosed at 29 in 1991. The foundation he built has reshaped how Parkinson's research is funded, and his public honesty about the disease, including the more recent realities of falls and broken bones, has done more to demystify Parkinson's than any patient education campaign ever has. Brian Grant, the former NBA player, runs a foundation focused on fitness for people with Parkinson's. There are others. Their visibility helps. None of them owe us the role of inspiration, and they have all said so in their own ways.
What I want you to leave this piece with is this: Parkinson's is a long disease, and it is not the end of a life. It is the beginning of a different way of living in a body, and a different way of being held by the people around you. The medications work. The exercise works. The community works. The hardest parts can be carried — not alone, and not all at once, but carried.
The man whose wife I mentioned at the beginning told me, near the end of her life, that the years after her diagnosis turned out to be some of the closest of their marriage. He said it without sentimentality. He said it like a fact, the way he might have read a weather report. I have thought about that often. Whatever this disease takes, it does not get to take everything. That part is still ours.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a neurologist, ideally one with movement disorder training, about any symptoms or treatment decisions.
